Chargement en cours...
Study Sets Response Benchmarks for FLT3‐Inhibitor Sequencing in FLT3‐Mutated AML
A new study of sequential exposure to FLT3 inhibitors demonstrates the benefits of these therapies across multiple lines and treatment settings for patients with FLT3‐mutated acute myeloid leukemia.
Enregistré dans:
| Publié dans: | Oncologist |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869113/ https://ncbi.nlm.nih.gov/pubmed/33368881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13648 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|